Special Considerations regarding Detection of Contaminants in Antiretrovirals and Use of Nelfinavir for Pregnant Women and Children in Resource-Poor Countries

Get This Resource

English: Web site

Summary

Contamination found in European stocks of nelfinavir sparked concern about its safety for children and pregnant women. The WHO and the FDA issued statements regarding nelfinavir safety. An ARV alert, by Dr. Susa Coffey, summarizes these concerns. Further commentary is provided by Dr. Arthur Ammann.